Finally, the ability of new-generation ICMs to automatically record arrhythmic episodes suggests that these devices could also be used to study asymptomatic ... 1): from bradycardia to asystole ...

Two strategies to manage asymptomatic severe AS are typically performed; clinical surveillance (CS), with routine monitoring and aortic valve replacement only when symptoms developed, or aortic ...

A transcatheter aortic valve replacement platform was approved for severe asymptomatic aortic stenosis. Edwards Lifesciences’ TAVR platform is the first to be approved in this population.

The US Food and Drug Administration (FDA) has approved Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement (TAVR) platform for the treatment of patients with asymptomatic severe ...

Asymptomatic patients with severe aortic stenosis can now undergo transcatheter aortic valve replacement, thanks to the US Food and Drug Administration’s approval of the new indication for the balloon ...

Approval of the SAPIEN 3 platform (SAPIEN 3, SAPIEN 3 Ultra and SAPIEN 3 Ultra RESILIA) is based on groundbreaking data from the EARLY TAVR trial, which demonstrated that asymptomatic severe AS ...

In that trial, among 901 people over age 65 with asymptomatic severe aortic stenosis, low surgical risk, and preserved left ventricular ejection fraction (LVEF), upfront TAVR resulted in fewer ...

is based on positive results from the EARLY TAVR study designed to evaluate TAVR compared to watchful waiting for patients with asymptomatic severe AS. With a median follow-up of 3.8 years ...

atrial fibrillation and sinus bradycardia). Including studies on neonates, only one study investigating rhythm disturbances during abstinence from cocaine found a significant but transient ...